Hemas Overview

  • Year Founded
  • 1948

Year Founded

  • Status
  • Public

  • Employees
  • 5,826

Employees

  • Stock Symbol
  • HHL.N0000

Stock Symbol

  • Investments
  • 8

  • Share Price
  • $0.26
  • (As of Tuesday Closing)

Hemas General Information

Description

Hemas Holdings PLC holds investments in companies with diversified businesses in Sri Lanka. Its businesses include manufacturing, trading, and distributing FMCG products, pharmaceutical products, healthcare products, provision of medical care, operating tourism business, hotel management, airlines, and shipping business, among others. It has the following reportable segments: Consumer, Healthcare, Mobility, and other segments. The healthcare segment which generates the majority of the revenue distributes pharmaceuticals, surgical and diagnostics products, and owns and manages hospitals. Geographically, the company generates a majority of its revenue from Sri Lanka.

Contact Information

Website
www.hemas.com
Formerly Known As
Hemas Drugs (Pvt.) Ltd.
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Holding Companies
Other Industries
Other Transportation
Other Healthcare Services
Stock Exchange
COL
Corporate Office
  • 75, Braybrooke Place
  • Colombo, 00002
  • Sri Lanka
+94 0114 000 000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hemas Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.26 $0.26 $0.20 - $0.30 $156M 597M 436K $0.03

Hemas Financials Summary

In Thousands,
USD
TTM 31-Mar-2024 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022
EV 182,088 182,088 150,488 70,376
Revenue 378,390 378,390 316,123 379,798
EBITDA 42,252 42,252 34,426 40,444
Net Income 19,006 19,006 11,844 20,469
Total Assets 309,018 309,018 295,545 255,947
Total Debt 41,891 41,891 64,383 22,028
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hemas Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hemas‘s full profile, request access.

Request a free trial

Hemas Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Hemas Holdings PLC holds investments in companies with diversified businesses in Sri Lanka. Its businesses include manuf
Holding Companies
Colombo, Sri Lanka
5,826 As of 2024
00.000
000.00 0000-00-00
00000000 00.000

0000 0

irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nul
0000000 0000000000
Colombo, Sri Lanka
00000 As of 0000
0000
0000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hemas Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
John Keells Holdings Corporation Colombo, Sri Lanka 00000 0000 0000 0000
You’re viewing 1 of 1 competitors. Get the full list »

Hemas Executive Team (11)

Name Title Board Seat
Kasturi Wilson Chief Executive Officer & Board Member
Ravi Jayasekera Acting Chief Executive Officer
Zalmi Fazeel Group Chief Financial Officer
Rizny Faisal Director & Head, Group Mergers & Acquisitions and Strategy
Gavin Mudalige Manager, Group Mergers & Acquisitions and Strategy
You’re viewing 5 of 11 executive team members. Get the full list »

Hemas Board Members (14)

Name Representing Role Since
000000 00000000 Self Chairman & Board Member 000 0000
000000 00000000 Hemas Board Member 000 0000
0000000 000000 Hemas Chief Executive Officer & Board Member 000 0000
00000 0000000000 0 Self Independent Non Executive Director - Hemas Power PLC 000 0000
0000000 0000000000 Hemas Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Hemas Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hemas Investments & Acquisitions (8)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Atlas Axillia 14-Jun-2023 000000000 000.00 Business Equipment and Supplies 0000000 0
Evergreen Shipping Agency Lanka 01-Jan-2019 00000 0000 Logistics
Atlas Axillia 19-Jan-2018 0000000000 000.00 Business Equipment and Supplies 000000 00
JB Power 18-Apr-2017 0000000000 00000 Energy Infrastructure
Morison 30-May-2013 Merger/Acquisition 000.00 Pharmaceuticals 000000 00
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Hemas Subsidiaries (2)

Company Name Industry Location Founded
Atlas Axillia Business Equipment and Supplies Peliyagoda, Sri Lanka 1959
Morison Pharmaceuticals Colombo, Sri Lanka 0000
To view Hemas’s complete subsidiaries history, request access »

Hemas ESG

Risk Overview

Risk Rating

Updated April, 27, 2024

38.71 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,216

Rank

00.0

Percentile

Industrial Conglomerates

Industry

00 of 137

Rank

00.0

Percentile

Conglomerates

Subindustry

00 of 137

Rank

00.0

Percentile

To view Hemas’s complete esg history, request access »

Hemas Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
echannelling 13-Nov-2005 0000 Completed
  • 4 buyers
To view Hemas’s complete exits history, request access »

Hemas FAQs

  • When was Hemas founded?

    Hemas was founded in 1948.

  • Who is the CEO of Hemas?

    Kasturi Wilson and Ravi Jayasekera are the CEOs of Hemas.

  • Where is Hemas headquartered?

    Hemas is headquartered in Colombo, Sri Lanka.

  • What is the size of Hemas?

    Hemas has 5,826 total employees.

  • What industry is Hemas in?

    Hemas’s primary industry is Holding Companies.

  • Is Hemas a private or public company?

    Hemas is a Public company.

  • What is Hemas’s stock symbol?

    The ticker symbol for Hemas is HHL.N0000.

  • What is the current stock price of Hemas?

    As of 23-Jul-2024 the stock price of Hemas is $0.26.

  • What is the current market cap of Hemas?

    The current market capitalization of Hemas is $156M.

  • What is Hemas’s current revenue?

    The trailing twelve month revenue for Hemas is $378M.

  • Who are Hemas’s competitors?

    John Keells Holdings is a competitor of Hemas.

  • What is Hemas’s annual earnings per share (EPS)?

    Hemas’s EPS for 12 months was $0.03.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »